title: Insulin-dose-adjusted HbA1c-defined partial remission phase in a paediatric population--when is the honeymoon over?
authors.forename: O M
authors.initials: OM
authors.lastname: Neylon
authors.forename: M
authors.initials: M
authors.lastname: White
authors.forename: M A
authors.initials: MA
authors.lastname: O Connell
authors.forename: F J
authors.initials: FJ
authors.lastname: Cameron
mesh_terms: D017668:Age of Onset; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000188:drug therapy* / Q000453:epidemiology; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*; D008297:Male; D012075:Remission, Spontaneous; D012189:Retrospective Studies
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; C517652:hemoglobin A1c protein, human